First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors

Schanz, Moritz; Seikrit, Claudia; Hohenstein, Bernd; Zimmermann, Aline; Kraft, Leonie; Schricker, Severin; Berger, Susann; Schwab, Andrea; Oberacker, Tina; Latus, Joerg

dc.contributor.author	Oberacker, Tina
dc.date.accessioned	2026-02-20T09:22:45Z
dc.date.available	2026-02-20T09:22:45Z
dc.date.issued	2025
dc.identifier.issn	2048-8505
dc.identifier.uri	http://hdl.handle.net/10900/176007
dc.language.iso	en	en
dc.publisher	Oxford : Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/ckj/sfae394
dc.subject.ddc	610	de_DE
dc.title	First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_01985
utue.personen.roh	Schanz, Moritz
utue.personen.roh	Seikrit, Claudia
utue.personen.roh	Hohenstein, Bernd
utue.personen.roh	Zimmermann, Aline
utue.personen.roh	Kraft, Leonie
utue.personen.roh	Schricker, Severin
utue.personen.roh	Berger, Susann
utue.personen.roh	Schwab, Andrea
utue.personen.roh	Oberacker, Tina
utue.personen.roh	Latus, Joerg
dcterms.isPartOf.ZSTitelID	Clinical Kidney Journal	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	18	de_DE
utue.fakultaet